PROCEPT BioRobotics (PRCT) Shares Outstanding (Weighted Average) (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $56.5 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $56.5 million, up 2.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.5 million (up 2.9% YoY), and the FY2025 annual result was $55.5 million, up 6.56% from the prior year.
• Shares Outstanding (Weighted Average) improved to $56.5 million in Q1 2026 per PRCT's latest filing, from $55.5 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $56.5 million in Q1 2026 and troughed at $43.9 million in Q1 2022.
• A 5-year average of $49.8 million and a median of $51.0 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) soared 807.97% in 2022, then grew 1.58% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $44.4 million in 2022, then increased by 6.43% to $47.3 million in 2023, then gained by 10.31% to $52.1 million in 2024, then gained by 6.56% to $55.5 million in 2025, then rose by 1.74% to $56.5 million in 2026.
• Business Quant data shows PRCT's Shares Outstanding (Weighted Average) at $56.5 million in Q1 2026, $55.5 million in Q4 2025, and $55.4 million in Q3 2025.